APHIS Highlights Biosecurity Advancements

USDA’s Animal and Plant Health Inspection Service recently highlighted many of the advancements in AG biosecurity in 2020. Under Secretary for Marketing and Regulatory Programs Greg Ibach, said among the highlights, progress on a Foot and Mouth vaccine bank. “We were able to negotiate a very attractive contract that allowed us to purchase basically double […]

USDA Announces FMD Vaccine Bank Investment

On Wednesday, the USDA announced the initial purchase of vaccines for the National Animal Vaccine and Veterinary Countermeasures Bank. USDA’s Animal and Plant Health Inspection Service will invest $27.1 million for foot-and-mouth disease vaccines, which the agency would use in the event of an outbreak. The vaccine bank was created in the 2018 farm bill. […]

USDA Working To Prepare For Livestock Diseases

One of the goals of the 2018 Farm Bill is to enhance the protection of the livestock industry from diseases.  To help with that effort, the USDA has increased the amount of money going toward three efforts.   “Our animal disease preparedness and response our national animal health laboratories network abilities as well as our […]

Could The U.S. Vacinate Against Foot And Mouth Into the Future?

When the United States gets a Foot and Mouth vaccine bank fully established, could livestock producers and vaccinate animals ahead of any outbreak like we do with some other diseases?   One expert says it’s not an option.   Iowa State University animal health expert Dr. James Roth one reason it’s not an option is […]

Vaccine Bank Critical, Says Animal Health Expert

In the years from 1870 to 1929, the US had nine Foot and Mouth Disease outbreaks.  At the time, animal health officials reacted by stopping the movement of all animals in the effected regions, and destroying the animals.  However that approach did not work.  Iowa State University animal health expert Dr. James Roth said today […]

Boehringer-Ingelheim Developing World’s Largest Vaccine Production Facility

Boehringer Ingelheim is developing a biotechnology production site for veterinary vaccines in Europe.  A groundbreaking ceremony last month marked the start of construction on the site that may become the largest vaccine production facility in the world.   According to the company, the 200-million-euro investment will significantly increase production capacities for antigens and vaccines against […]